Guner Ali
Karadeniz Technical University, Farabi Hospital, Department of General Surgery, Trabzon, Turkey.
Transl Gastroenterol Hepatol. 2017 Apr 26;2:31. doi: 10.21037/tgh.2017.04.01. eCollection 2017.
Gastric cancer is the fifth most common type of cancer and is the fourth most common death due to cancer in Turkey. Incidence and mortality rates are one of the highest among European countries. Despite the high rates, management of gastric cancer is still an issue of debate in Turkey and national guidelines have yet to be established. While the treatment plan following the diagnosis of gastric cancer is determined by a multidisciplinary meeting at high-volume centers, the plan in the majority of cases in Turkey is decided based on the decision of an individual physician. The primary goal of the treatment strategy is to obtain the best oncological outcomes and quality of life within the acceptable treatment-related morbidity. Therefore, R0 resection is intended by using standardized surgery with an individualized approach, while avoiding surgery if a curative resection is not possible. In this review, presenting on the recent trends of gastric cancer treatment including surgical, endoscopic, adjuvant/neoadjuvant and conversion treatment options in Turkey are aimed by exploring the institutional approach.
胃癌是第五大常见癌症类型，在土耳其是因癌症导致死亡的第四大常见病因。发病率和死亡率在欧洲国家中处于最高水平之一。尽管发病率和死亡率很高，但胃癌的管理在土耳其仍是一个有争议的问题，国家指南尚未制定。虽然在大型中心，胃癌诊断后的治疗方案由多学科会议决定，但在土耳其，大多数病例的治疗方案是由个别医生决定的。治疗策略的主要目标是在可接受的与治疗相关的发病率范围内获得最佳的肿瘤学结果和生活质量。因此，通过采用标准化手术和个体化方法来实现R0切除，而如果无法进行根治性切除则避免手术。在本综述中，旨在通过探索机构方法来介绍土耳其胃癌治疗的最新趋势，包括手术、内镜、辅助/新辅助和转化治疗选择。
